Several observations indicate that the Raf-1 kinase is a downstream eector of protein kinase C-e (PKCe). We recently have shown that Raf-1 is constitutively activated in PKCe transformed Rat6 ®broblasts, and transformation can be reverted by expression of a dominant negative Raf-1, but not a dominant negative Ras mutant (Cacace et al., 1996) . Cai et al. (1997) demonstrated that PKCe induced proliferation of NIH3T3 cells is independent of Ras or Src, but depends on Raf-1. These authors further suggested that PKCe activates Raf-1 by direct phosphorylation. Here we have investigated the functional interaction between PKCe and Raf-1. PKCe, but not PKCa, was found to bind to the Raf-1 kinase domain. The association appeared to be direct, as it could be reconstituted in vitro with puri®ed proteins. Raf-1 and PKCe could be co-precipitated from Sf-9 insect cells and PKCe transformed NIH313 cells (NIH/ e). The association was negatively regulated by ATP in vitro and by TPA treatment in NIH/e cells, but not in Sf-9 insect cells. Raf-1 was constitutively activated in NIH/e cells. However, using coexpression experiments in Sf-9 cells and transiently transfected A293 cells we did not obtain any evidence for a direct activation of Raf-1 by PKCe. PKCe did not induce translocation of Raf-1 to the membrane. Furthermore, PKCe did not activate Raf-1 nor enhance the kinase activity of Raf-1 that had been pre-activated by coexpression of Ras or the Lck tyrosine kinase. In contrast, conditioned media from PKCe transformed cells induced a robust activation of Raf-1. This activation could be partially reproduced by recombinant TGFb, a growth factors secreted by PKCe transformed Rat6 cells. In conclusion, our results suggest that PKCe stimulates Raf-1 indirectly by inducing the production of autocrine growth factors.
Introduction
The Raf-1 kinase is at the heart of intracellular signaling pathways that govern proliferation, differentiation and apoptosis. It is therefore not surprising that the activity of Raf-1 is regulated by a wide array of growth factors, cytokines and other compounds including tumor promoting phorbol esters, such as TPA. Despite major progress in the last years the mechanism of Raf-1 activation is still not fully understood and comprises regulation at several levels, such as subcellular distribution, interaction with associated proteins, dimerization, interaction with lipids, and phosphorylation on tyrosine and/or serine/ threonine residues (reviewed by Gajewski and Thompson, 1996; Morrison, 1995; Daum et al., 1994; Marshall, 1996; Marais and Marshall, 1996) . It seems that dierent growth factors utilize dierent combinations of these processes to regulate Raf-1, but it is not clear yet, which steps are required for Raf-1 activation, although phosphorylation seems obligatory. One main pathway leading to Raf-1 activation involves binding to activated Ras proteins resulting in the translocation of Raf-1 from the cytosol to the membrane, where Raf-1 becomes activated by yet unidenti®ed kinases (recently reviewed by Marais and Marshall, 1996) . Candidates include tyrosine kinases, such as Src (Williams et al., 1992; Marais et al., 1995) , Lck (Thompson et al., 1991) and JAK (Xia et al., 1996) as well as PKC (Carroll and May, 1994; Sozeri et al., 1992; Kolch et al., 1993) .
PKC is a family of eleven known isozymes, which can be sorted into three groups according to their structural and biochemical properties (e.g. reviewed by Dekker et al., 1995; Goodnight et al., 1994) . The classical PKCs (a, b 1 , b 2 and g) require calcium ions, diacylglycerol or TPA, and phospholipids for full activity. The novel PKCs (e, m, d, m, y) lack the calcium binding domain and hence are calcium independent. They are TPA responsive, and some of them can also be activated by speci®c phosphatidylinositides. The atypical PKCs (l/i, z) do neither bind TPA nor calcium, and seem to be solely regulated by lipids. The PKC isozymes appear to serve speci®c, mostly non-redundant functions in various cellular processes including the control of growth and dierentiation (reviewed by Dekker et al., 1995) . PKCe even has oncogenic traits when overexpressed in ®broblasts (Mischak et al., 1993b; Cacace et al., 1993) or colon epithelial cells (Perletti et al., 1996) . Raf-1 and its main downstream eector pathway, the MEK/ERK kinase cascade, are constitutively activated in PKCe transformed Rat6 cells (Cacace et al., 1996) . Moreover, transformation can be reversed by dominant negative Raf-1, but not dominant negative Ras, suggesting that Raf-1 is a downstream eector of PKCe (Cacace et al., 1996) .
We and others have previously reported that classical PKCs can activate Raf-1 by direct phosphorylation (Carroll and May, 1994; Sozeri et al., 1992; Kolch et al., 1993) and synergize with Raf-1 in transformation (Kolch et al., 1993) . Recent reports also have implicated the novel PKCs-d and -e in the activation of Raf-1 and the MEK/ERK kinases downstream of Raf-1 (Cai et al., 1997; Cacace et al., 1996; Malarkey et al., 1996; Ueda et al., 1996) . In COS-1 cells PKCd activates the MEK/ERK pathway in a Raf-1 dependent and Ras independent manner (Ueda et al., 1996) . Cai et al. (1997) have reported that PKCe activates Raf-1 and overcomes the growth inhibitory eects of dominant negative Ras in NIH3T3 cells. These authors also suggested that PKCe activates Raf-1 by direct phosphorylation. In the course of our studies on the role of PKCe in Raf-1 regulation, we did not obtain evidence for a direct activation. Our results rather suggest that PKCe induces the secretion of growth factors which potently activate Raf-1 via an autocrine loop.
Results
The interaction between PKCe and Raf-1 in Sf-9 cells and in vitro PKCe was expressed in Sf-9 cells together with GSTtagged Raf-1 constructs, including full-length human Raf-1 (G-raf), the isolated Raf-1 kinase domain (GNX), and GRS, which lacks the core of the kinase domain, i.e. amino acids 332 ± 597. GST-Raf proteins were isolated by adsorption to glutathione sepharose beads and examined for associated PKCe (Figure 1a ). PKCe did not bind to GRS, but speci®cally associated with the Raf-1 kinase domain. TPA treatment of the cells prior to harvest slightly diminished the binding to G-raf, but not to GNX. To assay the in¯uence of ATP and PKC activating phospholipids, G-Raf immobilized on glutathione sepharose beads was tested for binding of puri®ed PKCe or PKCa in vitro (Figure 1b) . While no association of PKCa could be detected, PKCe bound to Raf-1 under all conditions. Addition of ATP decreased the association, whereas the PKC activators diacylglycerol and phosphatidylserine had no significant eect.
PKCe does not directly activate the Raf-1 kinase
The binding of PKCe to Raf-1 prompted us to investigate, whether PKCe can activate Raf-1 directly. Surprisingly, we did not ®nd any evidence for direct activation of Raf-1 by PKCe. Coexpression of PKCe with Raf-1 in Sf-9 cells did not activate Raf-1, not even when the cells were stimulated with TPA prior to harvest (Figure 2a ). The same negative results were obtained with GNX, histidine-tagged or untagged Raf-1 (data not shown). In contrast, coexpression of PKCa under the same conditions induced a 3 ± 5-fold activation of these Raf-1 proteins (HaÈ fner et al., 1994; Mischak et al., 1996) , and data not shown.
In mammalian cells PKCe appears to be activated by the delayed rise in diacylglycerol (DAG) stemming from the hydrolysis of phosphatidylcholine (PC) rather than by the DAG acutely generated from phosphatidylinositol-bisphosphate(4,5) hydrolysis (Exton, 1994; Ha and Exton, 1993) . Since mitogen mediated Raf-1 activation usually ensues within a few minutes in a Ras dependent manner, PKCe may speci®cally act on preactivated Raf-1 to further increase its kinase activity. To examine this possibility Raf-1 was activated by coexpression of oncogenic Ras or the Lck tyrosine kinase in Sf-9 cells (Figure 2a) . Coexpression of PKCe did not aect the stimulation of Raf-1 by Ras or Lck in Sf-9 cells and failed to augment Raf-1 activation by Ras or Lck. These results are at odds with the ®ndings of Cai et al. (1997) , who reported that PKCe can not only activate Raf-1 by direct phosphorylation, but is able to further increase the kinase activity of Ras/Lck preactivated Raf-1. Furthermore, in our hands puri®ed PKCe only poorly phosphorylated Raf-1 in vitro and failed to increase the catalytic activity of Raf-1. These negative results were obtained with several dierent PKCe preparations, which all displayed high phosphotransferase activity towards histone and myelin basic protein. Vice versa, Raf-1, dominant negative Raf-1 (Raf301) or Ras/Lck activated Raf-1 did not alter the catalytic activity of PKCe in Sf-9 cells or in vitro (data not shown).
Our ®ndings were con®rmed by transient transfection assays in mammalian COS (data not shown) and A293 cells (Figure 2b ), which express PKCa as the predominant endogenous PKC isoform (Carroll and May, 1994) . TPA readily stimulated the Raf-1 kinase, and this activation was blocked by a dominant negative Raf-1 mutant (Raf301). This pattern of Raf-1 stimulation was not signi®cantly altered by coexpression of PKCe suggesting that TPA triggered Raf-1 activation was due to endogenous PKCa, and not transfected PKCe.
The interaction between Raf-1 and PKCe in stably transfected NIH3T3 cells
The results obtained above argued against a direct activation of Raf-1 by PKCe. PKCe can eciently
anti-PKCε blot b a Figure 1 PKCe binds to the Raf-1 kinase domain. (a) Association of PKCe with Raf proteins in Sf-9 cells. GST-tagged Raf-1 proteins corresponding to full-length Raf-1 (G-raf), the regulatory domain (GRS) or the kinase domain (GNX) were coexpressed with PKCe in Sf-9 cells. Where indicated cells were treated with 100 ng/ml TPA for 20 min. GST-Raf proteins were puri®ed by adsorption to glutathione sepharose beads, separated by SDS ± PAGE and blotted. Associated PKCe was visualized by staining with PKCe antibodies. (b) Association of PKCe with Raf-1 in vitro. GST or GST-Raf-1 proteins were immobilized on glutathione sepharose beads and incubated with puri®ed PKCe or PKCa. Where indicated, 1 mM ATP or 100 ng/ml phosphatidylserine and 20 ng/ml diacylglycerol (Ps/Do) were included during the binding reaction. The beads were washed, separated by SDS ± PAGE and blotted. PKCs were stained with speci®c antisera. The lane labeled`input' contains 10% of the total amount of PKCs added to the Raf-beads transform NIH3T3 and Rat6 ®broblasts (Cacace et al., 1993; Mischak et al., 1993b) , leading to the constitutive activation of the Raf-1/MEK/ERK cascade (Cai et al., 1997) . We, therefore, further investigated the mechanism of PKCe mediated Raf-1 stimulation in NIH3T3 cells stably transfected with PKCe, termed NIH/e (Mischak et al., 1993a) (Figure 3 ). These cells overexpress PKCe approximately 12-fold above endogenous levels, but contain comparable levels of Raf-1 (Mischak et al., 1993a) , and (Figure 3b and c). As shown in Figure 3a , Raf-1 could be coprecipitated with PKCe from lysates of detergent extracted serum starved cells (Figure 3a ). Very little coprecipitation was observed in TPA stimulated or logarithmically growing cells, suggesting that in NIH3T3 cells the interaction is regulated.
In NIH/e cells a fraction of PKCe is constitutively membrane associated (Goodnight et al., 1995) and Figure 3b ). As Raf-1 can be activated by translocation to the membrane (Stokoe et al., 1994; Leevers et al., 1994) , we speculated that PKCe may cause the activation of Raf-1 by relocating Raf-1 to the membrane. To test this possibility cytoplasmic (S100) and particulate (P100) fractions of parental NIH and NIH/e cells were prepared and examined for Raf-1 kinase activity (Figure 3b ). In serum starved parental NIH3T3 cells very little Raf-1 kinase activity was detected. TPA activated Raf-1 ®rst became apparent in the P100 fraction (after 5 min) and later (after 30 min) redistributed to the cytosol (S100). In contrast, NIH/e cells contained constitutively activated Raf-1, which, however, was found in the cytoplasmic fraction, and whose activity was only slightly enhanced by TPA. A delayed increase of Raf-1 activity in the particulate fraction became apparent after 30 min of TPA stimulation. Notably, the subcellular distribution of Raf-1 was not signi®cantly altered by PKCe overexpression. The direct examination of PKCe and Raf-1 distribution by Western blotting of the same P100 and S100 fractions (Figure 3c ) showed that TPA induced the rapid translocation of PKCe to the particulate fraction, being already clearly visible after 5 min of treatment. In contrast, the distribution of Raf-1 did not change. Taken together, these observations indicated that PKCe mediated Raf-1 activation may proceed by a dierent mechanism, which may be indirect, and could, for instance, involve the induction of autocrine growth factors by PKCe.
PKCe activates Raf-1 via autocrine growth factors
Our analysis of conditioned media (CM) from PKCe transformed Rat6 cells has revealed the presence of several mitogenic factors including TGFb (Cacace et al., submitted) . Therefore, we tested CM from vector control (R6-C1) and PKCe transformed Rat6 cells (R6-PKCe) for activation of the Raf-1 kinase ( Figure  4a ). CMs were applied to serum starved Rat6 cells, and (a) GST-Raf-1 or PKCe (`Pe') were expressed in Sf-9 cells alone (`w/o') or in combination with Ras or Lck. Where indicated cells were treated with 100 ng/ml TPA for 20 min. GST-Raf-1 was isolated with glutathione sepharose beads and subjected to a linked kinase assay using MEK-1 and kinase negative ERK-2 (MAPK-) as previously described (HaÈ fner et al., 1994) . The kinase reactions were electrophoresed on SDS-gels and blotted. The blots were autoradiographed (`kinase assay') and subsequently stained with Raf-1 and PKCe speci®c antisera to visualize the GST-Raf-1 proteins and associated PKCe. PKCe was immunoprecipitated and immunoblotted with anity puri®ed PKCe antibodies (Gibco/ BRL). As control, PKCe was expressed alone and immunoprecipitated. The PKCe precipitates failed to phosphorylate MEK-1 and MAPK-, thus eliminating a possible contribution of associated PKCe to the Raf-1 kinase activity. (b) A293 cells were transfected with the indicated expression plasmids. Raf301 is a kinase negative Raf-1 mutant. Forty-eight hours post transfection cells were serum starved and treated with 100 ng/ml TPA for 15 min as indicated. Endogenous Raf-1 was immunoprecipitated and its kinase activity was measured as described above. Kinase reactions were blotted, autoradiographed and stained with Raf-1 antiserum. The stronger Raf bands apparent in immunoblots of the samples transfected with Raf301 re¯ect the overexpression of Raf301, which diers from endogenous Raf-1 only by the inactivating point mutation in the ATP binding site, and hence is also precipitated by the Raf-1 antiserum Raf-1 kinase activity was measured. CM from control cells transiently stimulated the Raf-1 kinase, whereas CM from R6-PKCe cells caused a much stronger and more sustained induction. CM from TPA treated R6-PKCe cells was much more ecient in stimulating Raf-1 kinase activity than CM from untreated R6-PKCe cells. The CM mediated activation of Raf-1, however, was not caused by residual TPA in the CMs, since CM obtained from TPA treated parental Rat6 cells did not activate Raf-1 better than CM collected from untreated R6-PKCe cells Figure 4a and data not shown).
As one of the growth factors made by R6-PKCe cells was identi®ed as TGFb, we examined whether recombinant TGFb could activate Raf-1 (Figure 4b ). TGFb clearly induced Raf-1 kinase activity, albeit less eciently than CM from R6-PKCe cells, indicating that TGFb is one, but not the only, factor contained in R6-PKCe CM that is capable of activating Raf-1. The concentration of TGFb (2 ng/ml) used to assay Raf-1 activation was saturating as gauged by its biological activity to induce DNA synthesis (Cacace et al., submitted) . Higher concentrations of TGFb (up to 20 ng/ml) did not further improve Raf-1 activation. In conclusion our results suggest that PKCe stimulates Raf-1 by induction of autocrine factors rather than by direct activation.
Discussion
In this report we have investigated the mechanism of Raf-1 activation by PKCe. We have previously reported that the Raf-1 kinase is constitutively activated in PKCe transformed cells and shown that PKCe transformation depends on Raf-1. Here we show that Raf-1 activation is not mediated through direct activation of Raf-1 by PKCe, but rather by autocrine growth factors produced by PKCe transformed cells. from PKCe transformed (NIH/e) and parental NIH3T3 cells, which were harvested in the logarithmic growth phase (`growing'), after 20 h of serum withdrawal (`starved') or after serum starvation followed by TPA (100 ng/ml) treatment for 15 min (`+TPA'). The immunoprecipitates were resolved by SDS ± PAGE and blotted. The blot was sequentially stained with Raf-1 and PKCe speci®c antisera. As control puri®ed PKCe was loaded in the rightmost lane. (b) Serum starved NIH or NIH/e cells were treated with TPA and fractionated into cytosolic (`S100') and particulate compartments (`P100'). Raf-1 immunoprecipitates were subjected to a linked kinase assay, separated by SDS ± PAGE and blotted. Blots were autoradiographed and then stained with Raf-1 antiserum using ECL. The kinase reactions were exposed for the same time, while the anti-Raf-1 Western blot of the P100 fraction was exposed longer than the S100 blot (15 min versus 2 min) to visualize the minute amounts of Raf-1 partitioned into the particulate fraction. In the lane labeled`Co.' a MEK-1/MAPK-kinase reaction performed in the absence of a Raf-1 immunoprecipitate was loaded. (c) The left panel shows the protein levels of PKCe in parental and NIH/e cells as determined by Western blot analysis of crude cell lysates. The right panel shows the Western blot analysis of PKCe and Raf-1 distribution in the S100 (`S') and P100 (`P') fractions of in NIH/e cells. As fractionation control the distribution of Ras protein in shown, which exclusively is found in the P100 fraction
Our interpretation of the results contradicts the conclusions of Cai et al. (1997) , who suggested that PKCe stimulates the Raf-1 kinase directly. The reason for these discrepancies is not clear at present and can only in part be explained by the use of dierent reagents. For instance, in several independent experiments we never observed Raf-1 activation upon coexpression of PKCe in Sf-9 cells, whereas Cai et al. reported a modest activation. These authors used Raf-1 immunoprecipitates, which in our hands are contaminated by several other unidenti®ed proteins unrelated to Raf-1. We have used GST-tagged Raf-1 proteins, which only contain one major contaminating band as judged by Coomassie staining. This band represents about 50 ± 80% of total protein in glutathione sepharose puri®ed GST-Raf-1 preparations, and was identi®ed as superoxide dismutase (SOD) by protein microsequencing (M. Eulitz and HM, unpublished data). SOD binds directly to glutathione sepharose beads even in the absence of GST-Raf-1. We, however, also did not observe activation of untagged Raf-1 immunoprecipitated from Sf-9 cells coinfected with PKCe. This dierence remains unresolved and has to await future studies. We also failed to reproduce the slight activation of puri®ed GST-Raf-1 by puri®ed PKCe in vitro reported by these authors. This discrepancy may relate to the fact that the PKCe preparations used in our study were puri®ed by a dierent scheme and were at least 50 ± 80% pure in contrast to the 10% purity reported by Cai et al. (1997) .
As our results argued against the activation of Raf-1 via direct phosphorylation by PKCe, we investigated other possibilities. Given the association of Raf-1 with PKCe, one hypothesis we explored was that PKCe may activate Raf-1 by translocating Raf-1 to the cell membrane. This possibility, however, seems unlikely, since in several independent experiments we could not ®nd a signi®cantly elevated redistribution of Raf-1 to the particulate compartment in PKCe transformed NIH3T3 or Rat6 cells (Figure 3 and data not  shown) . Moreover, the PKC inhibitor GF109203X, which completely inhibits PKCe transformation (Mischak et al., 1993a) , does not interfere with the translocation of PKCe to the membrane and does not alter the levels of membrane associated Raf-1 (data not shown). Thus, the PKCe induced Raf-1 activation does not seem to involve major alterations of the subcellular distribution of Raf-1.
As kinases often associate with their substrates, we also tested whether Raf-1 may be an upstream activator of PKCe. However, neither in Sf-9 cells nor in in vitro experiments we were able to obtain any evidence for the activation of PKCe by Raf-1. Therefore, the role of the association between Raf-1 and PKCe is unclear at present and warrants future experimentation.
The transforming potential of PKCe is at least in part related to its ability to induce the production of autocrine growth factors. A report by Cacace and colleagues shows that conditioned medium (CM) of PKCe transformed Rat6 cells (R6-PKCe) elicits DNA synthesis and morphological transformation in parental Rat6 cells. The production of transforming growth factors by R6-PKCe was markedly enhanced by TPA stimulation. Biochemical fractionation of the CMs followed up by Northern and Western blotting revealed the production of active TGFb by R6-PKCe, but not by parental Rat6 cells. Based on inhibition experiments with anti-TGFb antibodies, this study concludes that TGFb is one component which contributes to the mitogenic and transforming properties of R6-PKCe CM (Cacace et al., submitted) . TGFb is a multifacetted factor and its ability to stimulate or inhibit growth is highly dependent on the cell type and the interaction with other extracellular or intracellular stimuli (e.g. reviewed by Attisano et al., 1994) . For instance, TGFb induces growth arrest in mammary epithelial cells. When these cells are transformed by Ras they maintain their epithelial characteristics, but now TGFb fails to inhibit proliferation and the cells respond with ®broblastoid conversion and the acquisition of invasiveness (Oft et al., 1996) . Moreover, TGFb can stimulate growth in NIH3T3 ®broblasts (Li et al., 1993) . Therefore, the most plausible explanation for the activation of Raf-1 in PKCe transformed ®broblasts is the activation of autocrine loops by PKCe, which in turn stimulate Raf-1. In accordance with this hypothesis conditioned medium of PKCe transformed Rat6 cells caused a pronounced stimulation of Raf-1 kinase activity. The Raf-1 activation achieved by TGFb does not reach the levels induced by CM, indicating the TGFb contributes to the activation of the Raf-1 kinase, but is not solely responsible. Our eorts to identify and purify growth factors contained in CM of PKCe transformed Rat6 cells have yielded evidence for a complex composition comprising known, i.e. TGFb, as well as several novel factors (Cacace et al., submitted) . The induction of autocrine growth factors may be one mechanism how PKC can regulate proliferation and dierentiation of cells. For example, the TPA induced growth of melanoma cells also seems to be at least in part be due to the secretion of autocrine factors (Arita et al., 1992) . Overexpression of PKCb in Rat6 cells also leads to the production of growth factors. It is important to note, however, that at least in Rat6 ®broblasts individual PKC isozymes dier in their ability to induce growth factors. PKCa fails to initiate autocrine loops (Borner et al., 1995) , Raf-1 immunoprecipitates were examined for kinase activity using the linked kinase assay.
(b) Serum starved Rat6 cells were treated with recombinant TGFb (2 ng/ml) and Raf-1 kinase activity was measured as above. In order to ease the comparison of the relative induction of Raf-1 kinase, the phosphoimager quanti®cation of the MAPKphosphorylation is given below the lanes whereas PKCb and -e induce growth factors that possess clearly distinct biological activities (Borner et al., 1995; Cacace et al., submitted, R Hinrichs and M Ueng, unpublished data) . The identi®cation of such factors is the topic of ongoing work, and will be important to advance our understanding of the diverse actions of PKC isozymes.
Materials and methods

Reagents and antibodies
TPA and TGFb were purchased from LC Laboratories or Gibco/BRL. Gluatathione sepharose beads were from Pharmacia. Myelin basic protein and histone were from Sigma. Antibodies against PKCa and PKCe were obtained from Transduction Laboratories and Gibco/BRL, respectively. The Raf antiserum has been described previously (HaÈ fner et al., 1994) .
Cells
Cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) with high glucose (4.5 g/l), supplemented with 10% newborn calf serum (Gibco/BRL). The R6/PKCe cells that stably overexpress a full length cDNA encoding the epsilon isoform of PKC, and a vector control cell line, R6-C1, have been described previously (Cacace et al., 1993) . NIH/e cells represent a pool of NIH3T3 cells transfected with the MTH/PKCe expression vector (Mischak et al., 1993a) .
Transient transfections
For transfections cells were used at 20 ± 40% con¯uency. A293 cells were transfected by a calcium phosphate method modi®ed as described (Kieser et al., 1994) , COS-1 cells were transfected with DEAE-dextrane/chloroquine . One day after transfection cells were placed in serum free medium and harvested 16 ± 20 h later.
Preparation of conditioned culture medium
Nearly con¯uent cultures of R6-C1 or R6-PKCe cells were washed and then incubated in DMEM without serum supplemented with 10 ng/ml TPA. After 30 h the medium was collected and any cell debris was removed by centrifugation at 5000 g at 48C. The biological activity of each sample was veri®ed by testing an aliquot for induction of DNA synthesis in Rat6 cells.
Expression and puri®cation of recombinant proteins in Sf-9 cells
PKCe and PKCa were expressed in Sf-9 cells and puri®ed to near homogeneity as described previously . Activity of PKCs was tested with histone and myelin basic protein as substrates . The construction of a baculovirus transducing a glutathione S-transferase (GST) -tagged Raf-1 has been described previously (HaÈ fner et al., 1994) . Brie¯y, the human c-Raf-1 cDNA was cloned in frame downstream of the GST portion of the baculovirus transfer vector pGSTAcC5. The pGSTAcC5 vector (a kind gift from Gisela Heidecker) features a GST portion followed by thrombin cleavage site, a ®ve glycine linker region and a polylinker. In GNX most of the Raf-1 regulatory domain was eliminated by the deletion of amino acids 26 ± 303. GRS represents a Raf-1 mutant, where an internal StuI fragment encoding amino acids 332 ± 597 was deleted. This results in removal of almost the entire kinase domain, CR3. Sf-9 cells were infected with recombinant baculoviruses and harvested on day 3 post infection. Cells were lysed in TBST buer (20 mM TrisHCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% Triton) plus protease inhibitors (1 mM PMSF, 1 mg/ml Leupeptin) and phosphatase inhibitors (100 mM orthovanadate, 20 mM b-glycerophosphate, 2 mM sodium¯uoride and 2 mM sodium pyrophosphate). The lysate was centrifuged for 10 min at 15 000 r.p.m. at 48C and the supernanant was incubated with 100 ml of glutathione sepharose (Pharmacia) for 15 min at 48C under constant agitation. The beads were pelleted (1 min, 15 000 r.p.m., 4 C) and washed three times with 1 ml TBST and once in kinase buer (20 mM TrisHCl pH 7.4, 20 mM NaCl, 10 mM MgCl 2 ). These protein preparations were used for in vitro binding assays and kinase assays.
In vitro binding assays GST-tagged Raf proteins immobilized on glutathione sepharose were incubated with puri®ed PKCa or PKCe in kinase buer supplemented with 0.2% bovine serum albumine as nonspeci®c competitor for 1 h at 48C. Samples were washed three times with TBST and separated by SDS ± PAGE.
Immunoprecipitation, Raf and PKC kinase assays and Western blotting
These procedures were carried out as described previously (HaÈ fner et al., 1994) .
Cell fractionation
Cells were serum starved overnight and treated as described in the ®gure legends. After washing with ice cold PBS cells were lysed in isotonic buer (20 mM TrisHCl pH 7.4, 0.3 M sucrose, 1 mM PMSF, 1 mg/ml Leupeptin, 100 mM orthovanadate, 20 mM b-glycerophosphate, 2 mM sodium¯uoride and 2 mM sodium pyrophosphate) by mild sonication. Nuclei were removed by centrifugation at 3000 g for 10 min. The supernatant was further centrifuged at 100 000 g for 60 min. The supernatant corresponding to the cytosolic fraction (S100) was adjusted to 1% Triton X-100 and used for immunoprecipitation. The pellet (P100) was washed three times by resuspension in isotonic buer, and subsequently extracted in an equal volume of this buer containing 1% Triton X-100 for 1 h on ice to recover detergent soluble Raf-1. Insoluble matter was removed by centrifugation for 10 min at 10 000 g. The insoluble fraction did not contain kinase activity towards MEK, when assayed as described by (Stokoe et al., 1994) . The Triton-X100 soluble fraction was immunoprecipitated with Raf-1 antiserum. The quality of each frationation experiment was assured by examining the distribution of Ras, PKCa and -e between the S100 and P100 fractions by immunoblotting. Ras was only found in the P100 fraction PKCa was solely detected in the S100 fraction in serum starved cells, but completely redistributed to the P100 fraction after TPA stimulation. PKCe was found in both the S100 and P100 fractions in serum starved cells, but markedly accumulated in the P100 fraction after TPA treatment.
